Fig. 5

RCS curve of SHR with mortality. SHR was linearly associated with 28-day mortality (A, B, C) and 365-day mortality (D, E, F). Model 1 was unadjusted. Model 2 was adjusted for sex, age, and BMI. Model 3 was adjusted for sex, age, BMI, SOFA, SAPS II, CKD, hypertension, HF, RF, COPD, diabetes, malignancy, diuretics, vasoactive drugs, RRT, WBC, hemoglobin, RDW, platelet, creatinine, BUN, albumin, ALT, AST, TC, TG, potassium, sodium, chlorine, and glucose